100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
about
Allergen Immunotherapy: Past, Present, and FutureRecombinant allergens: the present and the futureStrategies to query and display allergy-derived epitope data from the immune epitope database.Allergen immunotherapy and allergic rhinitis: false beliefs.Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence.A xenograft mantle transplantation technique for producing a novel pearl in an akoya oyster host.Diagnosis and treatment of allergic diseases in Zhejiang Province: a cross-sectional survey.FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy.Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.Emerging therapies for food allergy.Specific immunotherapy in children: the evidence.The role of immunotherapy in the management of childhood asthma.Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.Fungi: the neglected allergenic sources.Modified allergens and their potential to treat allergic disease.Oral immunotherapy for the treatment of food allergy.Grass pollen immunotherapy: where are we now.Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.Mithridates VI Eupator king of Pontus and the venomous snakes.A modified, hypoallergenic variant of the Ricinus communis Ric c1 protein retains biological activity.[Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].Candidin and trichophytin stimulate the production of Th1 and regulatory cytokines by peripheral blood mononuclear cells: implication for their use as adjuvants in immunotherapy.[Immunological mechanisms of allergen-specific immunotherapy].Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthmaSuperparamagnetic iron oxide nanoparticles conjugated to a grass pollen allergen and an optical probeThe dose response principle from philosophy to modern toxicology: The impact of ancient philosophy and medicine in modern toxicology science
P2860
Q26765974-91B60660-3A74-4AA8-A007-5800C9A752CAQ26996701-264E1439-12BB-4E12-A938-1C47504A9840Q30578181-53313FC4-7FF4-4550-ACFE-89D91AD062F3Q33643094-70691938-9D0C-41F8-B6BE-E24E91EE934AQ33802263-8E194280-95DB-41ED-91D5-D51F37C503DBQ34881801-4D9B0B88-6639-48C3-A761-846D7B2103F5Q35864853-F654234F-FE82-418E-8C75-FBE15ED66262Q36118977-1A99E5D6-EEF3-4412-BD5C-645BF011DE6CQ36302500-4B430ECD-3D57-4BC5-A7E0-7DB9A52E1FA2Q37726651-D95D51A3-0B07-4664-9083-13F9A782D4BBQ37950136-835FFEE5-9854-4B10-94E3-5E6282F3FFD8Q37995986-C08CB929-5FF2-4003-BA71-A0D6C370397BQ38134763-D6D82DA8-B86F-408B-B2EC-875739987E7BQ38167038-0EF86170-D27B-496A-910D-1F3C9CBBE944Q38255585-C59B366C-D6E0-4760-91CB-3455AD2E63C9Q38271442-BF2A1B51-0D95-49ED-B7C8-8A88E7D42084Q38773340-60FAFB98-E93B-48FB-A558-8FE08D639C72Q39282520-8FD6C4FF-71E1-4DDF-AA28-A44D3117046EQ41014277-C44EE1BA-6F58-4F7F-9055-161F3FCD3FC0Q52695058-351D8F00-F286-4CE0-8318-8510B0D36824Q52734773-C9D56ED5-33E3-48DC-98E7-F9A75A9C5B21Q52785931-E7D78C35-F827-4128-8F6F-A1A91C5EF0DEQ53514860-8E042011-1394-4AD8-A1B3-4A5DF00AB836Q54525833-89FA45AF-3E42-45F1-98DF-AAA438E0249DQ57814018-145D93D3-5003-467A-8884-53FD71B50981Q58885379-189809F1-0B01-4526-B031-8EB7F1D54CDAQ59137414-A8438E11-0BD7-4A04-856D-A9255229F7DF
P2860
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
@en
100 years of hyposensitization: history of allergen-specific immunotherapy
@nl
type
label
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
@en
100 years of hyposensitization: history of allergen-specific immunotherapy
@nl
prefLabel
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
@en
100 years of hyposensitization: history of allergen-specific immunotherapy
@nl
P2860
P1433
P1476
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
@en
P2093
J Gutermuth
Johannes Ring
P2860
P304
P356
10.1111/J.1398-9995.2010.02541.X
P577
2011-02-15T00:00:00Z